Anavex Life Sciences Corp. Made Headway
Anavex Life Sciences Corp. (AVXL:NASDAQ) jumped higher at $21.06, a gain of 21.5%. The stock appeared on our News Catalysts scanner on Tue, Jun 15, 2021 at 03:02 AM in the 'MISCELLANEOUS' category. From Tue, Jun 01, 2021, the stock recorded 90.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Jun 14, 2021 at $22.24 with a volume of 17M+.
About Anavex Life Sciences Corp. (AVXL:NASDAQ)
Anavex Life Sciences Corp is a clinical stage bio-pharmaceutical company. The Company is engaged in the developments drug candidates to treat Alzheimer's disease, other central nervous system (CNS) diseases, and various types of cancer.
Top 10 Gainers:
- ORPH (ORPH:NASDAQ), 61.29%
- Kindred Biosciences, Inc. (KIN:NASDAQ), 45.58%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 21.45%
- UTME (UTME:NASDAQ), 20.41%
- GTT Communications, Inc. (GTT:NYSE), 20%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 18.95%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 18.15%
- OPT (OPT:NASDAQ), 17.48%
- AUVI (AUVI:NASDAQ), 17.39%
- Altimmune, Inc. (ALT:NASDAQ), 16.49%